Evidence for postinitiation regulation of mRNA biogenesis in tuberculosis

Journal of Immunology

Volumn 190, Issue 6, 2013, Pages 2747-2755

  Salamon, Hugh ^a   Qiao, Yaming ^b   Cheng, Jeff C ^c,f   Yamaguchi, Ken D ^a   Soteropoulos, Patricia ^b   Weiden, Michael ^d   Gennaro, Maria Laura ^b,e   Pine, Richard ^b,e  

^a Knowledge Synthesis Inc   (United States)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^c NEW JERSEY INSTITUTE OF TECHNOLOGY   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^f MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1; MESSENGER RNA; NUCLEAR RNA; STAT1 PROTEIN; TRANSCRIPTOME;

ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DOWN REGULATION; GAMBIA; GENE EXPRESSION; HOST RESISTANCE; HUMAN; HUMAN CELL; IN VITRO STUDY; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; TUBERCULOSIS; UNITED KINGDOM;

CELL LINE; DOWN-REGULATION; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON-GAMMA; LATENT TUBERCULOSIS; MACROPHAGES, ALVEOLAR; MYCOBACTERIUM TUBERCULOSIS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION; TUBERCULOSIS, PULMONARY;

EID: 84874915401     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202185     Document Type: Article

References (64)

1. Corbett, E. L., C. J.Watt, N.Walker, D. Maher, B. G.Williams, M. C. Raviglione, and C. Dye. 2003. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163: 1009-1021
2. Enarson, D. A., C.-Y. Chiang, and J. F. Murray. 2004. Global epidemiology of tuberculosis. In Tuberculosis, 2nd Ed. W. N. Rom, and S. M. Garay, eds. Lippincott Williams &Wilkins, New York, p. 13-29
3. Kim, H. R., S. S. Hwang, H. J. Kim, S. M. Lee, C. G. Yoo, Y. W. Kim, S. K. Han, Y. S. Shim, and J. J. Yim. 2007. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis. Clin. Infect. Dis. 45: 1290-1295
4. Sotgiu, G., G. Ferrara, A. Matteelli, M. D. Richardson, R. Centis, S. Ruesch- Gerdes, O. Toungoussova, J. P. Zellweger, A. Spanevello, D. Cirillo, et al. 2009. Epidemiology and clinical management of XDR-TB: a systematic review by TBNET. Eur. Respir. J. 33: 871-881
5. Ernst, J. D. 2012. The immunological life cycle of tuberculosis. Nat. Rev. Immunol. 12: 581-591
6. Chan, J., and J. Flynn. 2004. The immunological aspects of latency in tuberculosis. Clin. Immunol. 110: 2-12
7. Durbin, J. E., R. Hackenmiller, M. C. Simon, and D. E. Levy. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84: 443-450
8. Meraz, M. A., J. M. White, K. C. F. Sheehan, E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riley, A. C. Greenlund, D. Campbell, et al. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84: 431-442
9. Kamijo, R., H. Harada, T. Matsuyama, M. Bosland, J. Gerecitano, D. Shapiro, J. Le, S. I. Koh, T. Kimura, S. J. Green, et al. 1994. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263: 1612-1615
10. Martin, E., C. Nathan, and Q.-W. Xie. 1994. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180: 977-984
11. Chapgier, A., R. F. Wynn, E. Jouanguy, O. Filipe-Santos, S. Zhang, J. Feinberg, K. Hawkins, J. L. Casanova, and P. D. Arkwright. 2006. Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo. J. Immunol. 176: 5078-5083
12. Dupuis, S., E. Jouanguy, S. Al-Hajjar, C. Fieschi, I. Z. Al-Mohsen, S. Al- Jumaah, K. Yang, A. Chapgier, C. Eidenschenk, P. Eid, et al. 2003. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat. Genet. 33: 388-391
13. Sugawara, I., H. Yamada, and S. Mizuno. 2004. STAT1 knockout mice are highly susceptible to pulmonary mycobacterial infection. Tohoku J. Exp. Med. 202: 41-50
14. Yamada, H., S. Mizuno, and I. Sugawara. 2002. Interferon regulatory factor 1 in mycobacterial infection. Microbiol. Immunol. 46: 751-760
15. Pine, R., T. Decker, D. S. Kessler, D. E. Levy, and J. E. Darnell, Jr. 1990. Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both beta interferon- and interferonstimulated genes but is not a primary transcriptional activator of either. Mol. Cell. Biol. 10: 2448-2457
16. Pine, R., A. Canova, and C. Schindler. 1994. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFN a and IFN g, and is likely to autoregulate the p91 gene. EMBO J. 13: 158-167
17. Weiden, M., N. Tanaka, Y. Qiao, B. Y. Zhao, Y. Honda, K. Nakata, A. Canova, D. E. Levy, W. N. Rom, and R. Pine. 2000. Differentiation of monocytes to macrophages switches the Mycobacterium tuberculosis effect on HIV-1 replication from stimulation to inhibition: modulation of interferon response and CCAAT/enhancer binding protein b expression. J. Immunol. 165: 2028-2039
18. Ting, L. M., A. C. Kim, A. Cattamanchi, and J. D. Ernst. 1999. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. J. Immunol. 163: 3898-3906
19. Qiao, Y., S. Prabhakar, E. M. Coccia, M. Weiden, A. Canova, E. Giacomini, and R. Pine. 2002. Host defense responses to infection by Mycobacterium tuberculosis. Induction of IRF-1 and a serine protease inhibitor. J. Biol. Chem. 277: 22377-22385
20. Prabhakar, S., Y. Qiao, Y. Hoshino, M. Weiden, A. Canova, E. Giacomini, E. Coccia, and R. Pine. 2003. Inhibition of response to alpha interferon by Mycobacterium tuberculosis. Infect. Immun. 71: 2487-2497
21. Qiao, Y., S. Prabhakar, A. Canova, Y. Hoshino, M. Weiden, and R. Pine. 2004. Posttranscriptional inhibition of gene expression by Mycobacterium tuberculosis offsets transcriptional synergism with IFN-gamma and posttranscriptional upregulation by IFN-gamma. J. Immunol. 172: 2935-2943
22. Topisirovic, I., Y. V. Svitkin, N. Sonenberg, and A. J. Shatkin. 2011. Cap and cap-binding proteins in the control of gene expression. Wiley Interdiscip Rev RNA 2: 277-298
23. Weake, V. M., and J. L. Workman. 2010. Inducible gene expression: diverse regulatory mechanisms. Nat. Rev. Genet. 11: 426-437
24. de Nadal, E., G. Ammerer, and F. Posas. 2011. Controlling gene expression in response to stress. Nat. Rev. Genet. 12: 833-845
25. Sims, R. J., III, R. Belotserkovskaya, and D. Reinberg. 2004. Elongation by RNA polymerase II: the short and long of it. Genes Dev. 18: 2437-2468
26. Shin, C., and J. L. Manley. 2004. Cell signalling and the control of pre-mRNA splicing. Nat. Rev. Mol. Cell Biol. 5: 727-738
27. Lutz, C. S. 2008. Alternative polyadenylation: a twist on mRNA 39 end formation. ACS Chem. Biol. 3: 609-617
28. Condino-Neto, A., and P. E. Newburger. 2000. Interferon-gamma improves splicing efficiency of CYBB gene transcripts in an interferon-responsive variant of chronic granulomatous disease due to a splice site consensus region mutation. Blood 95: 3548-3554
29. Ishibashi, F., T. Mizukami, S. Kanegasaki, L. Motoda, R. Kakinuma, F. Endo, and H. Nunoi. 2001. Improved superoxide-generating ability by interferon g due to splicing pattern change of transcripts in neutrophils from patients with a splice site mutation in CYBB gene. Blood 98: 436-441
30. Leeman, J. R., and T. D. Gilmore. 2008. Alternative splicing in the NF-kappaB signaling pathway. Gene 423: 97-107
31. Jaresová, I., D. Rozková, R. Spísek, A. Janda, J. Brázová, and A. Sedivá. 2007. Kinetics of Toll-like receptor-4 splice variants expression in lipopolysaccharidestimulated antigen presenting cells of healthy donors and patients with cystic fibrosis. Microbes Infect. 9: 1359-1367
32. Leung, E., J. Hong, A. Fraser, and G. W. Krissansen. 2007. Splicing of NOD2 (CARD15) RNA transcripts. Mol. Immunol. 44: 284-294
33. Kobayashi, K., L. D. Hernandez, J. E. Galán, C. A. Janeway, Jr., R. Medzhitov, and R. A. Flavell. 2002. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110: 191-202
34. Janssens, S., K. Burns, J. Tschopp, and R. Beyaert. 2002. Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88. Curr. Biol. 12: 467-471
35. Hardy, M. P., and L. A. O'Neill. 2004. The murine IRAK2 gene encodes four alternatively spliced isoforms, two of which are inhibitory. J. Biol. Chem. 279: 27699-27708
36. Shell, S. A., C. Hesse, S. M. Morris, Jr., and C. Milcarek. 2005. Elevated levels of the 64-kDa cleavage stimulatory factor (CstF-64) in lipopolysaccharidestimulated macrophages influence gene expression and induce alternative poly (A) site selection. J. Biol. Chem. 280: 39950-39961
37. Robinson, R. T., S. A. Khader, C. A. Martino, J. J. Fountain, M. Teixeira-Coelho, J. E. Pearl, S. T. Smiley, G. M. Winslow, D. L. Woodland, M. J. Walter, et al. 2010. Mycobacterium tuberculosis infection induces il12rb1 splicing to generate a novel IL-12Rbeta1 isoform that enhances DC migration. J. Exp. Med. 207: 591-605
38. Park, E., M. S. Lee, S. M. Baik, E. B. Cho, G. H. Son, J. Y. Seong, K. H. Lee, and K. Kim. 2009. Nova-1 mediates glucocorticoid-induced inhibition of pre-mRNA splicing of gonadotropin-releasing hormone transcripts. J. Biol. Chem. 284: 12792-12800
39. Friedman, C. R., G. C. Quinn, B. N. Kreiswirth, D. C. Perlman, N. Salomon, N. Schluger, M. Lutfey, J. Berger, N. Poltoratskaia, and L. W. Riley. 1997. Widespread dissemination of a drug-susceptible strain of Mycobacterium tuberculosis. J. Infect. Dis. 176: 478-484
40. Riendeau, C. J., and H. Kornfeld. 2003. THP-1 cell apoptosis in response to Mycobacterial infection. Infect. Immun. 71: 254-259
41. Sly, L. M., M. Lopez, W. M. Nauseef, and N. E. Reiner. 2001. 1alpha,25- Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J. Biol. Chem. 276: 35482-35493
42. Boulikas, T. 1988. At least 60 ADP-ribosylated variant histones are present in nuclei from dimethylsulfate-treated and untreated cells. EMBO J. 7: 57-67
43. Pine, R., D. E. Levy, N. Reich, and J. E. Darnell, Jr. 1988. Transcriptional stimulation by CaPO4-DNA precipitates. Nucleic Acids Res. 16: 1371-1378
44. Choe, S. E., M. Boutros, A. M. Michelson, G. M. Church, and M. S. Halfon. 2005. Preferred analysis methods for Affymetrix GeneChips revealed by a wholly defined control dataset. Genome Biol. 6: R16
45. Baldi, P., and A. D. Long. 2001. A Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changes. Bioinformatics 17: 509-519
46. Ashburner, M., C. A. Ball, J. A. Blake, D. Botstein, H. Butler, J. M. Cherry, A. P. Davis, K. Dolinski, S. S. Dwight, J. T. Eppig, et al; The Gene Ontology Consortium. 2000. Gene ontology: tool for the unification of biology. Nat. Genet. 25: 25-29
47. Berry, M. P., C. M. Graham, F. W. McNab, Z. Xu, S. A. Bloch, T. Oni, K. A. Wilkinson, R. Banchereau, J. Skinner, R. J. Wilkinson, et al. 2010. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973-977
48. Maertzdorf, J., M. Ota, D. Repsilber, H. J. Mollenkopf, J. Weiner, P. C. Hill, and S. H. Kaufmann. 2011. Functional correlations of pathogenesis-driven gene expression signatures in tuberculosis. PLoS ONE 6: e26938
49. Thuong, N. T., S. J. Dunstan, T. T. Chau, V. Thorsson, C. P. Simmons, N. T. Quyen, G. E. Thwaites, N. Thi Ngoc Lan, M. Hibberd, Y. Y. Teo, et al. 2008. Identification of tuberculosis susceptibility genes with human macrophage gene expression profiles. PLoS Pathog. 4: e1000229
50. Joshi-Tope, G., M. Gillespie, I. Vastrik, P. D'Eustachio, E. Schmidt, B. de Bono, B. Jassal, G. R. Gopinath, G. R. Wu, L. Matthews, et al. 2005. Reactome: a knowledgebase of biological pathways. Nucleic Acids Res. 33(Database issue): D428-D432
51. Croft, D., G. O'Kelly, G. Wu, R. Haw, M. Gillespie, L. Matthews, M. Caudy, P. Garapati, G. Gopinath, B. Jassal, et al. 2011. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res. 39(Database issue): D691-D697
52. Yamaguchi, K. D., D. L. Ruderman, E. Croze, T. C. Wagner, S. Velichko, A. T. Reder, and H. Salamon. 2008. IFN-βeta-regulated genes show abnormal expression in therapy-naïve relapsing-remitting MS mononuclear cells: gene expression analysis employing all reported protein-protein interactions. J. Neuroimmunol. 195: 116-120
53. Croze, E., K. D. Yamaguchi, V. Knappertz, A. T. Reder, and H. Salamon. 2012. Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis. Pharmacogenomics J. 10.1038/tpj.2012.27
54. Benjamini, Y., and Y. Hochberg. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc., B 57: 289-300
55. R Development Core Team. 2010. A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria
56. Kincaid, E. Z., and J. D. Ernst. 2003. Mycobacterium tuberculosis exerts geneselective inhibition of transcriptional responses to IFN-gamma without inhibiting STAT1 function. J. Immunol. 171: 2042-2049
57. Ehrt, S., D. Schnappinger, S. Bekiranov, J. Drenkow, S. Shi, T. R. Gingeras, T. Gaasterland, G. Schoolnik, and C. Nathan. 2001. Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J. Exp. Med. 194: 1123-1140
58. Gehring, A. J., R. E. Rojas, D. H. Canaday, D. L. Lakey, C. V. Harding, and W. H. Boom. 2003. The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2. Infect. Immun. 71: 4487-4497
59. Alvarez, G. R., B. S. Zwilling, and W. P. Lafuse. 2003. Mycobacterium avium inhibition of IFN-gamma signaling in mouse macrophages: Toll-like receptor 2 stimulation increases expression of dominant-negative STAT1 beta by mRNA stabilization. J. Immunol. 171: 6766-6773
60. Shi, S., C. Nathan, D. Schnappinger, J. Drenkow, M. Fuortes, E. Block, A. Ding, T. R. Gingeras, G. Schoolnik, S. Akira, et al. 2003. MyD88 primes macrophages for full-scale activation by interferon-gamma yet mediates few responses to Mycobacterium tuberculosis. J. Exp. Med. 198: 987-997
61. Pai, R. K., M. E. Pennini, A. A. Tobian, D. H. Canaday, W. H. Boom, and C. V. Harding. 2004. Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages. Infect. Immun. 72: 6603-6614
62. Wang, Y., H. M. Curry, B. S. Zwilling, and W. P. Lafuse. 2005. Mycobacteria inhibition of IFN-gamma induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells. J. Immunol. 174: 5687-5694
63. Sow, F. B., G. R. Alvarez, R. P. Gross, A. R. Satoskar, L. S. Schlesinger, B. S. Zwilling, and W. P. Lafuse. 2009. Role of STAT1, NF-kappaB, and C/ EBPbeta in the macrophage transcriptional regulation of hepcidin by mycobacterial infection and IFN-g. J. Leukoc. Biol. 86: 1247-1258
64. Benson, S. A., and J. D. Ernst. 2009. TLR2-dependent inhibition of macrophage responses to IFN-gamma is mediated by distinct, gene-specific mechanisms. PLoS ONE 4: e6329